Shin Nippon Biomedical Laboratories, Ltd.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: JP3379950003
JPY
1,470.00
21 (1.45%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
32,524.96
32,413.81
26,450.47
25,090.90
17,748.48
15,110.55
14,561.08
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
32,524.96
32,413.81
26,450.47
25,090.90
17,748.48
15,110.55
14,561.08
Raw Material Cost
16,698.15
15,842.83
12,429.26
12,268.91
8,220.14
7,706.41
7,093.31
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
293.22
202.75
138.78
125.06
126.65
184.86
235.01
Selling and Distribution Expenses
10,772.51
11,368.07
8,117.65
6,893.69
4,907.65
4,482.36
4,838.67
Other Expenses
210.72
201.49
160.24
55.80
29.84
20.74
16.58
Total Expenditure (Excl Depreciation)
29,871.05
29,428.59
22,288.11
19,845.67
13,552.87
12,581.01
12,332.83
Operating Profit (PBDIT) excl Other Income
2653.8999999999996
2985.2
4162.4
5245.2
4195.6
2529.5
2228.3
Other Income
3,035.50
3,461.57
2,942.55
4,095.71
4,053.86
2,587.52
774.73
Operating Profit (PBDIT)
9,121.36
9,057.87
8,972.90
10,941.42
9,426.90
6,304.74
4,232.14
Interest
293.22
202.75
138.78
125.06
126.65
184.86
235.01
Exceptional Items
851.33
-230.94
8.31
-1,456.27
60.49
-756.63
294.69
Gross Profit (PBDT)
15,826.81
16,570.97
14,021.21
12,821.99
9,528.34
7,404.14
7,467.77
Depreciation
3,431.95
2,611.09
1,867.98
1,600.47
1,177.43
1,187.68
1,229.15
Profit Before Tax
6,247.52
6,013.10
6,974.44
7,759.61
8,183.31
4,175.56
3,062.67
Tax
1,713.32
1,148.51
1,456.74
1,708.90
1,016.21
497.79
414.54
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4,566.70
4,924.85
5,531.26
6,060.06
7,127.63
3,661.86
2,550.38
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4,566.70
4,924.85
5,531.26
6,060.06
7,127.63
3,661.86
2,550.38
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-32.50
-60.26
-13.55
-9.35
39.48
15.92
97.75
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4,534.20
4,864.59
5,517.71
6,050.71
7,167.10
3,677.77
2,648.13
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
43,120.76
40,022.74
34,114.42
26,211.83
19,561.09
15,734.45
16,288.07
Earnings per share (EPS)
109.69
118.3
132.86
145.57
171.21
87.96
61.26
Diluted Earnings per share
109.69
118.3
132.86
145.57
171.21
87.96
61.26
Operating Profit Margin (Excl OI)
8.16%
9.21%
15.74%
20.9%
23.64%
16.74%
15.3%
Gross Profit Margin
29.76%
26.61%
33.43%
37.3%
52.74%
35.49%
29.47%
PAT Margin
14.04%
15.19%
20.91%
24.15%
40.16%
24.23%
17.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 0.34% vs 22.55% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -6.79% vs -11.84% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 8.75% vs -7.20% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 44.65% vs 46.04% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Shin Nippon Biomedical Laboratories, Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
32,524.96
1,21,458.00
-88,933.04
-73.22%
Other Operating Income
0.00
0.00
0.00
Total Operating income
32,524.96
1,21,458.00
-88,933.04
-73.22%
Raw Material Cost
16,698.15
91,201.00
-74,502.85
-81.69%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
293.22
11.00
282.22
2,565.64%
Selling and Distribution Expenses
10,772.51
20,728.00
-9,955.49
-48.03%
Other Expenses
210.72
150.60
60.12
39.92%
Total Expenditure (Excl Depreciation)
29,871.05
1,13,446.00
-83,574.95
-73.67%
Operating Profit (PBDIT) excl Other Income
2,653.91
8,012.00
-5,358.09
-66.88%
Other Income
3,035.50
3,222.00
-186.50
-5.79%
Operating Profit (PBDIT)
9,121.36
14,699.00
-5,577.64
-37.95%
Interest
293.22
11.00
282.22
2,565.64%
Exceptional Items
851.33
-981.00
1,832.33
186.78%
Gross Profit (PBDT)
15,826.81
30,257.00
-14,430.19
-47.69%
Depreciation
3,431.95
3,465.00
-33.05
-0.95%
Profit Before Tax
6,247.52
10,241.00
-3,993.48
-39.00%
Tax
1,713.32
3,015.00
-1,301.68
-43.17%
Provisions and contingencies
0
0
0.00
Profit After Tax
4,566.70
6,386.00
-1,819.30
-28.49%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
4,566.70
6,386.00
-1,819.30
-28.49%
Share in Profit of Associates
0
0
0.00
Minority Interest
-32.50
839.00
-871.50
-103.87%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4,534.20
7,225.00
-2,690.80
-37.24%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
43,120.76
71,924.00
-28,803.24
-40.05%
Earnings per share (EPS)
109.69
405.54
-295.85
-72.95%
Diluted Earnings per share
109.69
405.54
-295.85
-72.95%
Operating Profit Margin (Excl OI)
8.16%
6.60%
0.00
1.56%
Gross Profit Margin
29.76%
11.28%
0.00
18.48%
PAT Margin
14.04%
5.26%
0.00
8.78%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 3,252.50 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 0.34% vs 22.55% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 453.42 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is -6.79% vs -11.84% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 608.59 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 8.75% vs -7.20% in Mar 2025

Annual - Interest
Interest 29.32 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 44.65% vs 46.04% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.16%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025